Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Incyte Corporation(INCY) | 30,743,991 | 30,744,412 | +421 | $3.04B | $2.89B | 16.62% | -$142.92M |
| BeOne Medicines AGADS(ONC) | 8,799,053 | 8,799,053 | 0 | $2.67B | $2.61B | 15.00% | -$60.19M |
| Insmed Incorporated(INSM) | 6,592,746 | 7,421,111 | +828,365 | $1.15B | $1.21B | 6.97% | +$66.10M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 2,141,701 | 2,141,701 | 0 | $1.25B | $1.12B | 6.44% | -$126.08M |
| ACADIA Pharmaceuticals Inc. | 42,896,690 | 42,896,690 | 0 | $1.15B | $954.88M | 5.48% | -$190.89M |
| Revolution Medicines, Inc.(RVMD) | 9,455,357 | 9,555,357 | +100,000 | $753.12M | $929.26M | 5.34% | +$176.14M |
| Celcuity Inc.(CELC) | 7,915,792 | 7,915,792 | 0 | $789.52M | $903.51M | 5.19% | +$113.99M |
| Kodiak Sciences Inc.(KOD) | 19,919,186 | 19,919,186 | 0 | $556.94M | $759.32M | 4.36% | +$202.38M |
| Kymera Therapeutics, Inc.(KYMR) | 8,657,242 | 8,657,242 | 0 | $673.62M | $721.06M | 4.14% | +$47.44M |
| Summit Therapeutics Inc.(SMMT) | 36,391,063 | 36,391,063 | 0 | $636.48M | $689.97M | 3.96% | +$53.49M |
| Praxis Precision Medicines, Inc.(PRAX) | 1,126,488 | 1,753,198 | +626,710 | $332.02M | $564.86M | 3.24% | +$232.84M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 5,604,483 | 5,604,483 | 0 | $599.90M | $487.42M | 2.80% | -$112.48M |
| Alkermes plcSHS(ALKS) | 10,012,267 | 10,012,267 | 0 | $280.14M | $354.03M | 2.03% | +$73.89M |
| GRAIL, Inc.(GRAL) | 2,085,333 | 4,028,614 | +1,943,281 | $178.48M | $208.20M | 1.20% | +$29.72M |
| Edgewise Therapeutics, Inc.(EWTX) | 6,575,940 | 6,575,940 | 0 | $163.18M | $207.14M | 1.19% | +$43.96M |
| Ionis Pharmaceuticals, Inc.(IONS) | 1,791,841 | 2,047,727 | +255,886 | $141.75M | $153.76M | 0.88% | +$12.01M |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 2,826,246 | 2,826,246 | 0 | $116.58M | $136.08M | 0.78% | +$19.50M |
| Immunovant, Inc.(IMVT) | 5,457,881 | 5,457,881 | 0 | $138.74M | $135.57M | 0.78% | -$3.17M |
| Roivant Sciences Ltd.SHS(ROIV) | 5,555,017 | 4,867,723 | -687,294 | $120.54M | $134.84M | 0.77% | +$14.29M |
| IDEAYA Biosciences, Inc.(IDYA) | 3,618,826 | 3,946,515 | +327,689 | $125.10M | $131.50M | 0.76% | +$6.40M |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 2,175,645 | 1,992,783 | -182,862 | $144.44M | $124.95M | 0.72% | -$19.49M |
| Stoke Therapeutics, Inc.(STOK) | 3,336,697 | 3,336,697 | 0 | $105.91M | $108.64M | 0.62% | +$2.74M |
| Immatics N.V.SHS(IMTX) | 12,094,094 | 10,916,693 | -1,177,401 | $126.99M | $107.42M | 0.62% | -$19.57M |
| AbCellera Biologics Inc.(ABCL) | 27,525,640 | 30,275,938 | +2,750,298 | $94.14M | $105.66M | 0.61% | +$11.53M |
| ABIVAX Société AnonymeADS(ABVX) | 875,796 | 875,796 | 0 | $118.11M | $97.52M | 0.56% | -$20.59M |
| Crinetics Pharmaceuticals, Inc. | 1,648,869 | 2,351,465 | +702,596 | $76.75M | $85.41M | 0.49% | +$8.65M |
| Replimune Group, Inc.(REPL) | 11,045,336 | 11,045,336 | 0 | $107.36M | $84.50M | 0.49% | -$22.86M |
| Celcuity Inc.NOTE 2 75 8 1 2031(CELC) | 0 | 30,750,000 | +30,750,000 | $66.58M | $74.87M | 0.43% | +$8.29M |
| Nurix Therapeutics, Inc.(NRIX) | 4,658,556 | 4,658,556 | 0 | $88.37M | $72.21M | 0.41% | -$16.17M |
| Denali Therapeutics Inc.(DNLI) | 3,731,695 | 3,731,695 | 0 | $61.61M | $71.65M | 0.41% | +$10.04M |
| Dianthus Therapeutics, Inc.(DNTH) | 789,759 | 852,164 | +62,405 | $32.55M | $71.51M | 0.41% | +$38.97M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 4,345,736 | 4,345,736 | 0 | $68.14M | $71.49M | 0.41% | +$3.35M |
| Structure Therapeutics Inc.ADS | 1,432,529 | 1,432,529 | 0 | $99.63M | $69.05M | 0.40% | -$30.58M |
| Entrada Therapeutics, Inc.(TRDA) | 5,072,730 | 5,072,730 | 0 | $52.15M | $64.02M | 0.37% | +$11.87M |
| Bicycle Therapeutics plcADS | 10,885,357 | 10,885,357 | 0 | $77.07M | $50.51M | 0.29% | -$26.56M |
| Spyre Therapeutics, Inc.(SYRE) | 1,000,000 | 1,000,000 | 0 | $32.76M | $50.44M | 0.29% | +$17.68M |
| Rapport Therapeutics, Inc.(RAPP) | 1,547,090 | 1,547,090 | 0 | $46.94M | $48.41M | 0.28% | +$1.47M |
| Alumis Inc. | 1,562,500 | 2,012,500 | +450,000 | $15.25M | $44.34M | 0.25% | +$29.09M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 0 | 445,975 | +445,975 | $0 | $41.20M | 0.24% | +$41.20M |
| Viridian Therapeutics, Inc.(VRDN) | 1,971,678 | 1,971,678 | 0 | $61.36M | $38.57M | 0.22% | -$22.79M |
| Enliven Therapeutics, Inc. | 271,406 | 905,191 | +633,785 | $4.18M | $35.48M | 0.20% | +$31.30M |
| Prelude Therapeutics Incorporated(PRLD) | 10,123,824 | 10,123,824 | 0 | $29.36M | $34.62M | 0.20% | +$5.26M |
| DBV Technologies S.A.ADS(DBVT) | 1,461,425 | 1,461,425 | 0 | $28.02M | $30.53M | 0.18% | +$2.51M |
| Design Therapeutics, Inc.(DSGN) | 2,233,099 | 2,585,978 | +352,879 | $20.95M | $27.51M | 0.16% | +$6.57M |
| Centessa Pharmaceuticals plcADS | 670,751 | 670,751 | 0 | $16.78M | $26.64M | 0.15% | +$9.87M |
| CytomX Therapeutics, Inc.(CTMX) | 4,250,826 | 4,975,826 | +725,000 | $18.11M | $23.39M | 0.13% | +$5.28M |
| Jade Biosciences, Inc. | 1,641,137 | 1,641,137 | 0 | $25.32M | $23.06M | 0.13% | -$2.26M |
| Disc Medicine, Inc.(IRON) | 337,050 | 349,657 | +12,607 | $26.77M | $22.36M | 0.13% | -$4.41M |
| Immunocore Holdings plcADS(IMCR) | 2,322,656 | 734,397 | -1,588,259 | $80.62M | $22.14M | 0.13% | -$58.48M |
| Xenon Pharmaceuticals Inc.(XENE) | 370,208 | 370,208 | 0 | $16.59M | $21.53M | 0.12% | +$4.93M |
| Celldex Therapeutics, Inc.(CLDX) | 665,370 | 665,370 | 0 | $18.07M | $21.11M | 0.12% | +$3.03M |
| Neurogene Inc.(NGNE) | 991,691 | 991,691 | 0 | $20.43M | $19.99M | 0.11% | -$436.3K |
| Evommune, Inc.(EVMN) | 0 | 847,390 | +847,390 | $0 | $19.48M | 0.11% | +$19.48M |
| Tectonic Therapeutic, Inc.(TECX) | 903,400 | 607,788 | -295,612 | $18.84M | $18.79M | 0.11% | -$58.2K |
| Contineum Therapeutics, Inc.CL A(CTNM) | 1,420,838 | 1,420,838 | 0 | $16.24M | $18.56M | 0.11% | +$2.32M |
| argenx SEADR(ARGX) | 25,174 | 25,174 | 0 | $21.17M | $18.38M | 0.11% | -$2.79M |
| Cerus Corporation(CERS) | 10,008,345 | 10,008,345 | 0 | $20.62M | $18.22M | 0.10% | -$2.40M |
| Taysha Gene Therapies, Inc.(TSHA) | 4,004,756 | 4,004,756 | 0 | $22.03M | $17.90M | 0.10% | -$4.12M |
| Aktis Oncology, Inc.(AKTS) | 0 | 996,351 | +996,351 | $0 | $17.82M | 0.10% | +$17.82M |
| Generate Biomedicines, Inc.(GENB) | 0 | 1,423,602 | +1,423,602 | $0 | $17.80M | 0.10% | +$17.80M |
| Sionna Therapeutics, Inc.(SION) | 400,000 | 400,000 | 0 | $16.46M | $16.04M | 0.09% | -$420.0K |
| Dyne Therapeutics, Inc.(DYN) | 813,449 | 813,449 | 0 | $15.91M | $14.75M | 0.08% | -$1.16M |
| Xencor, Inc.(XNCR) | 1,102,106 | 1,102,106 | 0 | $16.87M | $13.29M | 0.08% | -$3.58M |
| COMPASS Pathways plcADS(CMPS) | 0 | 2,344,720 | +2,344,720 | $0 | $12.97M | 0.07% | +$12.97M |
| Relay Therapeutics, Inc.(RLAY) | 1,160,117 | 1,160,117 | 0 | $9.81M | $11.54M | 0.07% | +$1.73M |
| Sera Prognostics, Inc.CL A(SERA) | 5,498,170 | 5,498,170 | 0 | $16.22M | $11.16M | 0.06% | -$5.06M |
| BioNTech SEADS(BNTX) | 368,923 | 119,743 | -249,180 | $35.12M | $10.64M | 0.06% | -$24.48M |
| Pharvaris N.V. COM | 375,000 | 375,000 | 0 | $10.41M | $10.59M | 0.06% | +$187.5K |
| Arcus Biosciences, Inc.(RCUS) | 270,000 | 415,621 | +145,621 | $6.43M | $8.98M | 0.05% | +$2.54M |
| MapLight Therapeutics, Inc.(MPLT) | 364,705 | 364,705 | 0 | $6.41M | $7.41M | 0.04% | +$1.01M |
| Absci Corporation | 2,134,803 | 2,134,803 | 0 | $7.45M | $6.40M | 0.04% | -$1.05M |
| Wave Life Sciences, Inc.SHS(WVE) | 344,063 | 822,638 | +478,575 | $5.85M | $5.96M | 0.03% | +$115.1K |
| vTv Therapeutics Inc.CL A(VTVT) | 148,314 | 148,314 | 0 | $5.93M | $5.88M | 0.03% | -$48.9K |
| Eikon Therapeutics, Inc.(EIKN) | 0 | 555,555 | +555,555 | $0 | $5.88M | 0.03% | +$5.88M |
| Protara Therapeutics, Inc.(TARA) | 971,614 | 971,614 | 0 | $5.18M | $5.06M | 0.03% | -$116.6K |
| Sagimet Biosciences Inc.COM SER A(SGMT) | 952,996 | 952,996 | 0 | $5.64M | $4.98M | 0.03% | -$662.3K |
| LB Pharmaceuticals Inc(LBRX) | 200,000 | 200,000 | 0 | $4.45M | $4.93M | 0.03% | +$480.0K |
| Verastem, Inc.(VSTM) | 0 | 584,757 | +584,757 | $0 | $3.10M | 0.02% | +$3.10M |
| TScan Therapeutics, Inc.(TCRX) | 2,784,792 | 2,784,792 | 0 | $2.78M | $2.81M | 0.02% | +$27.8K |
| Skye Bioscience, Inc.(SKYE) | 1,450,638 | 1,575,243 | +124,605 | $1.09M | $968.1K | 0.01% | -$119.4K |
| Sana Biotechnology, Inc.(SANA) | 310,483 | 310,483 | 0 | $1.26M | $894.2K | 0.01% | -$369.5K |
| Aligos Therapeutics, Inc.(ALGS) | 83,055 | 83,055 | 0 | $774.1K | $617.1K | 0.00% | -$157.0K |
| Tyra Biosciences, Inc.(TYRA) | 10,607 | 10,607 | 0 | $278.9K | $406.2K | 0.00% | +$127.4K |
| Surrozen, Inc.W EXP 8 11 2026(SRZN) | 833,333 | 833,333 | 0 | $16.7K | $13.3K | 0.00% | -$3.3K |
| 4D Molecular Therapeutics, Inc. | 475,737 | 0 | -475,737 | $3.57M | $0 | — | -$3.57M |
| Acrivon Therapeutics, Inc. | 22,809 | 0 | -22,809 | $55.0K | $0 | — | -$55.0K |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 2,822,727 | 0 | -2,822,727 | $22.02M | $0 | — | -$22.02M |
| KALA BIO, Inc.(KALA) | 1,804,055 | 0 | -1,804,055 | $1.00M | $0 | — | -$1.00M |
| Nuvalent, Inc. | 143,937 | 0 | -143,937 | $14.48M | $0 | — | -$14.48M |
| Terns Pharmaceuticals, Inc. | 950,000 | 0 | -950,000 | $38.38M | $0 | — | -$38.38M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 2,772,692 | 0 | -2,772,692 | $63.77M | $0 | — | -$63.77M |
| Ventyx Biosciences, Inc. | 2,349,280 | 0 | -2,349,280 | $21.21M | $0 | — | -$21.21M |
| Vir Biotechnology, Inc.(VIR) | 542,539 | 0 | -542,539 | $3.27M | $0 | — | -$3.27M |